About Jason Norris
Form D filings for Mytide Therapeutics from 2022 to 2023 list Jason Norris as executive officer, director and promoter.
Jason Norris first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jason Norris in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jason Norris works with at each company, as listed on that company's latest Form D.
Mytide Therapeutics, Inc. · Form D, Jan 6, 2023
EA
Errik Anderson
Director
DT
Dale Thomas
Executive officer, director and promoter